Abstract
BRCA1 and BRCA2 account for most cases of familial, early onset breast and/or ovarian cancer and encode products that each interact with hRAD51. Results presented here show that BRCA1 and BRCA2 coexist in a biochemical complex and colocalize in subnuclear foci in somatic cells and on the axial elements of developing synaptonemal complexes. Like BRCA1 and RAD51, BRCA2 relocates to PCNA+ replication sites following exposure of S phase cells to hydroxyurea or UV irradiation. Thus, BRCA1 and BRCA2 participate, together, in a pathway(s) associated with the activation of double-strand break repair and/or homologous recombination. Dysfunction of this pathway may be a general phenomenon in the majority of cases of hereditary breast and/or ovarian cancer.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Antibodies, Monoclonal
-
BRCA1 Protein / analysis
-
BRCA1 Protein / metabolism*
-
BRCA2 Protein
-
Breast Neoplasms / genetics
-
Breast Neoplasms / pathology*
-
Cell Line
-
Cell Nucleus / ultrastructure
-
Chromosome Mapping
-
DNA Damage
-
DNA Repair
-
DNA Replication
-
DNA-Binding Proteins / analysis
-
DNA-Binding Proteins / genetics
-
Female
-
Genes, BRCA1*
-
Genes, Tumor Suppressor*
-
Humans
-
Meiosis
-
Mitosis
-
Neoplasm Proteins / analysis
-
Neoplasm Proteins / genetics*
-
Neoplasm Proteins / metabolism*
-
Ovarian Neoplasms / genetics
-
Rad51 Recombinase
-
Transcription Factors / analysis
-
Transcription Factors / genetics*
-
Transcription Factors / metabolism*
-
Transfection
-
Tumor Cells, Cultured
-
Zygote / cytology
Substances
-
Antibodies, Monoclonal
-
BRCA1 Protein
-
BRCA2 Protein
-
DNA-Binding Proteins
-
Neoplasm Proteins
-
Transcription Factors
-
RAD51 protein, human
-
Rad51 Recombinase